This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 221853 results found since Jan 2013.
Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults
Condition: HIV Infections Interventions: Drug: VH4004280; Drug: VH4011499; Drug: VH4004280 Matching Placebo; Drug: VH4011499 Matching Placebo Sponsor: ViiV Healthcare Not yet recruiting
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials
Notice of Technical Assistance Webinar and FAQs for NOT-HL-23-113 (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established longitudinal studies (R01 CT Optional)
Notice NOT-HL-23-111 from the NIH Guide for Grants and Contracts
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2023 Category: Research Source Type: funding
Cancer treatment delays among cancer patients living with HIV during the COVID ‐19 pandemic in the United States
Conclusions/RelevancePLWH experienced significant delays in cancer treatment initiation after diagnosis during the first year of COVID-19, delays that may negatively impact cancer outcomes. These data warrant patient and provider attention as the pandemic continues to impact the US healthcare system.
Source: Cancer Medicine - September 15, 2023 Category: Cancer & Oncology Authors: Ashley Khouri,
Jessica Y. Islam,
Nathan W. Van Bibber,
Anna E. Coghill,
Gita Suneja Tags: RESEARCH ARTICLE Source Type: research
Knowledge and behaviours associated with HIV infection and other sexually transmitted infections in blood donors in Italy
CONCLUSION: A more comprehensive and updated information on various STIs, transmission modes and safe sex should be provided to blood donors, not only to prevent the spread of these infections but also to avoid unjustified discrimination.PMID:37712234 | DOI:10.4415/ANN_23_03_02
Source: Annali dell Istituto Superiore di Sanita - September 15, 2023 Category: General Medicine Authors: Vincenza Regine Lucia Pugliese Alice Simonetti Francesco Marchionni Gianpietro Briola Vincenzo Saturni Barbara Suligoi Source Type: research
Differential Diagnosis or Etiology: A Case Report on Amyotrophic Lateral Sclerosis-like Neuropathy Associated with HIV Infection
CONCLUSION: After a short follow-up and viral load cleansing, neurological stabilization was achieved.PMID:37711011 | DOI:10.2174/1570162X21666230914104220
Source: Current HIV Research - September 15, 2023 Category: Infectious Diseases Authors: Renato Barradas Rodrigues Marco Orsini Sofia Vieira Neves Wladimir Bocca Vieira de Rezende Pinto Ant ônio Marcos da Silva Catarino Daniel Antunes Pereira Acary Souza Bulle Oliveira Source Type: research
Knowledge and behaviours associated with HIV infection and other sexually transmitted infections in blood donors in Italy
CONCLUSION: A more comprehensive and updated information on various STIs, transmission modes and safe sex should be provided to blood donors, not only to prevent the spread of these infections but also to avoid unjustified discrimination.PMID:37712234 | DOI:10.4415/ANN_23_03_02
Source: Ann Ist Super Sanita - September 15, 2023 Category: Biomedical Science Authors: Vincenza Regine Lucia Pugliese Alice Simonetti Francesco Marchionni Gianpietro Briola Vincenzo Saturni Barbara Suligoi Source Type: research
Differential Diagnosis or Etiology: A Case Report on Amyotrophic Lateral Sclerosis-like Neuropathy Associated with HIV Infection
CONCLUSION: After a short follow-up and viral load cleansing, neurological stabilization was achieved.PMID:37711011 | DOI:10.2174/1570162X21666230914104220
Source: Current HIV Research - September 15, 2023 Category: Infectious Diseases Authors: Renato Barradas Rodrigues Marco Orsini Sofia Vieira Neves Wladimir Bocca Vieira de Rezende Pinto Ant ônio Marcos da Silva Catarino Daniel Antunes Pereira Acary Souza Bulle Oliveira Source Type: research
Knowledge and behaviours associated with HIV infection and other sexually transmitted infections in blood donors in Italy
CONCLUSION: A more comprehensive and updated information on various STIs, transmission modes and safe sex should be provided to blood donors, not only to prevent the spread of these infections but also to avoid unjustified discrimination.PMID:37712234 | DOI:10.4415/ANN_23_03_02
Source: Annali dell Istituto Superiore di Sanita - September 15, 2023 Category: General Medicine Authors: Vincenza Regine Lucia Pugliese Alice Simonetti Francesco Marchionni Gianpietro Briola Vincenzo Saturni Barbara Suligoi Source Type: research
Mini Review on Clinical Aspects of Monkeypox
Curr Pharm Biotechnol. 2023 Sep 14. doi: 10.2174/1389201025666230914094444. Online ahead of print.ABSTRACTMonkeypox is a disease caused by the monkeypox virus, which is a type of orthopox virus that comes from the virus family Poxviridae. Its first case reported in animals and humans was in 1958 and 1970, respectively. It is a viral zoonosis disease with two modes of transmission: animal to human (via direct contact or eating the meat of an infected animal) and human to human (via contact or contact with skin lesions, body fluids, and infected person's contaminated objects). The literature depicts that monkeypox is less co...
Source: Current Pharmaceutical Biotechnology - September 15, 2023 Category: Biotechnology Authors: Yash Saraswat Kamal Shah Source Type: research
Evolution of HIV virulence in response to disease-modifying vaccines: A modeling study
Vaccine. 2023 Sep 13:S0264-410X(23)01027-7. doi: 10.1016/j.vaccine.2023.08.071. Online ahead of print.ABSTRACTPathogens face a tradeoff with respect to virulence; while more virulent strains often have higher per-contact transmission rates, they are also more likely to kill their hosts earlier. Because virulence is a heritable trait, there is concern that a disease-modifying vaccine, which reduces the disease severity of an infected vaccinee without changing the underlying pathogen genotype, may result in the evolution of higher pathogen virulence. We explored the potential for such virulence evolution with a disease-modif...
Source: Vaccine - September 15, 2023 Category: Allergy & Immunology Authors: Molly C Reid John E Mittler James T Murphy Sarah E Stansfield Steven M Goodreau Neil Abernethy Joshua T Herbeck Source Type: research
Mini Review on Clinical Aspects of Monkeypox
Curr Pharm Biotechnol. 2023 Sep 14. doi: 10.2174/1389201025666230914094444. Online ahead of print.ABSTRACTMonkeypox is a disease caused by the monkeypox virus, which is a type of orthopox virus that comes from the virus family Poxviridae. Its first case reported in animals and humans was in 1958 and 1970, respectively. It is a viral zoonosis disease with two modes of transmission: animal to human (via direct contact or eating the meat of an infected animal) and human to human (via contact or contact with skin lesions, body fluids, and infected person's contaminated objects). The literature depicts that monkeypox is less co...
Source: Current Pharmaceutical Biotechnology - September 15, 2023 Category: Biotechnology Authors: Yash Saraswat Kamal Shah Source Type: research
Knowledge and behaviours associated with HIV infection and other sexually transmitted infections in blood donors in Italy
CONCLUSION: A more comprehensive and updated information on various STIs, transmission modes and safe sex should be provided to blood donors, not only to prevent the spread of these infections but also to avoid unjustified discrimination.PMID:37712234 | DOI:10.4415/ANN_23_03_02
Source: Annali dell'Istituto Superiore di Sanita - September 15, 2023 Category: International Medicine & Public Health Authors: Vincenza Regine Lucia Pugliese Alice Simonetti Francesco Marchionni Gianpietro Briola Vincenzo Saturni Barbara Suligoi Source Type: research
Control groups for HIV prevention efficacy trials: what does the future hold?
Curr Opin HIV AIDS. 2023 Sep 12. doi: 10.1097/COH.0000000000000818. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Ending the HIV epidemic will require the development of additional effective immune-mediated and nonimmune-mediated means of HIV prevention. Evaluating novel interventions requires large, controlled trials demonstrating efficacy. Recent advances in the field of HIV prevention necessitate new approaches to efficacy trial design.RECENT FINDINGS: Three classes of efficacy trial designs are possible: standard of prevention-controlled trials, active-controlled trials, and active-controlled trials augmented with e...
Source: Cancer Control - September 15, 2023 Category: Cancer & Oncology Authors: Holly Janes Susan Buchbinder Source Type: research
